NIH Public Access Author Manuscript Sex Transm Infect. Author manuscript; available in PMC 2013 June 04.

Similar documents
Effect of Endocervical Specimen Adequacy for Detection of ACCEPTED. Wyoming Public Health Laboratory, 517 Hathaway Bldg., 2300 Capitol Ave.

Evaluation of CDC-Recommended Approaches for Confirmatory Testing of Positive Neisseria gonorrhoeae Nucleic Acid Amplification Test Results

ACCEPTED. Instrument in Female Self-obtained Vaginal Swabs and Male Urine Samples. Andrew Hardick 1. Justin Hardick 1.

2014 CDC GUIDELINES CHLAMYDIA & GONORRHEA DIAGNOSTICS. Barbara Van Der Pol, PhD, MPH University of Alabama at Birmingham

Professor Jonathan Ross

Screening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016

Rapid Antigen Testing Compares Favorably with Transcription-Mediated Amplification Assay for the Detection of Trichomonas vaginalis in Young Women

OBJECTIVES. Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections

Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections

Industry Sponsored Symposia. Québec City, CANADA JULY 10 TO 13,

Received 12 March 2007/Returned for modification 20 June 2007/Accepted 27 September 2007

4. RED AND BLUE TOP COLLECTION SWABS WILL NO LONGER BE SUPPLIED FOR BACTERIAL CULTURE

LABORATORY VALIDATION OF XPERT CT/NG AND TV TESTING AS PERFORMED BY NURSES AT THREE PRIMARY HEALTHCARE FACILITIES IN SOUTH AFRICA

Comparison of Three Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis in Urine Specimens

Use of Nucleic Acid Amplification Testing for the Diagnosis of Anorectal Sexually. Transmitted Infections. Lisa A. Cosentino 1,2.

UPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH. Dr Arlo Upton Clinical Microbiologist Labtests Auckland

Performance of the Abbott RealTime CT/NG for the Detection of Chlamydia. trachomatis and Neisseria gonorrhoeae

Performance of the Abbott RealTime CT/NG for Detection of

New CT/GC Tests. CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009

Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing

CDC Laboratory Update

Received 26 November 2008/Returned for modification 4 February 2009/Accepted 2 April 2009

Control Efforts for Trichomoniasis in STD Clinics

STI control. Dr. Jane Morgan Hamilton Sexual Health Clinic

Departments of Medicine and Epidemiology, Division of Infectious Diseases, University of Alabama at Birmingham

Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014

Technical Bulletin No. 98b

CHLAMYDIA/GC AMPLIFIED RNA ASSAY

Controls for Chlamydia trachomatis and Neisseria gonorrhoea

Transmission from the Oropharynx to the Urethra among Men who have Sex with Men

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

MYCOPLASMA GENITALIUM FEASABILITY AND PITFALLS OF ADJUNCT TESTING FOR MACROLIDE RESISTANCE (a.k.a. no test is 100%)

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

APTIMA Combo 2 Testing Detected Additional Cases of Neisseria. gonorrhoeae in Men and Women in Community Settings. * Corresponding Author at:

Unprotected sex in an STD clinic population: Agreement between self-reported condom use and PCR detection of y-chromosome in vaginal fluid

Controls for Chlamydia trachomatis and Neisseria gonorrhoea

Prevalence of Trichomonas vaginalis and Coinfection with Chlamydia trachomatis and

Extragenital Chlamydia and Gonorrhea. Angel Stachnik, MPH Sr. Epidemiologist Office of Epidemiology and Disease Surveillance

Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think?

Rate and Predictors of Repeat Chlamydia trachomatis Infection Among Men

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

Strategies to achieve STI control in South Africa Prof Remco Peters

Received 26 November 2003/Returned for modification 6 January 2004/Accepted 6 April 2004

1 VU University Medical Centre, Department of Medical Microbiology & Infection Control, Laboratory of

7/13/2018. NEW TESTS - Please update your EMR catalog with those appropriate to your practice

DETECTION OF NEISSERIA GONORRHOEAE USING MOLECULAR METHODS

Clinical Microbiology

Assessment of co-infection of Sexually Transmitted pathogen microbes by

NIH Public Access Author Manuscript Sex Transm Dis. Author manuscript; available in PMC 2009 July 16.

Original Study. Culture of Non-Genital Sites Increases the Detection of Gonorrhea in Women

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and

Services for GLBTQ Youth

Answers to those burning questions -

Nucleic Acid Amplification Tests for Diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis Rectal Infections

Processing of female genital specimens at Labtests and Northland Pathology Laboratory

Evaluation of the new BD MAX GC real time PCR assay, analytically and clinically as a

New diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018

Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313

Mycoplasma genitalium:

7/24/2012. Estimates of Sexually Transmitted Infections in the U.S.

Nucleic acid amplification testing for Neisseria gonorrhoeae where are we going?

Lymphogranuloma Venereum (LGV) Surveillance Project

Sexually Transmitted Infections In Manitoba

Mycoplasma Genitalium: Get to Know the Hidden STI

Prevalence of Mycoplasma genitalium and Azithromycin-Resistant. Infections Among Remnant Clinical Specimens, Los Angeles ACCEPTED

5/1/2017. Sexually Transmitted Diseases Burning Questions

Performance of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification assays using low level controls

FEDERAL PUBLIC SERVICE, HEALTH, FOOD CHAIN SECURITY AND ENVIRONMENT CLINICAL BIOLOGY COMMISSION CLINICAL BIOLOGY SECTION

Guidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011

STI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council

Trichomonas Time to Know the Facts

OAML Guideline on the Investigation of Genital Tract Infections November, 2015

SOME ETIOLOGIES OF STI OBJECTIVES CHLAMYDIA TRENDING. Things are Heating Up: An Update on Emerging Sexually-transmitted Infection Agents

GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS

Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018

amplification assay and BD Affirm VPIII for detection of Trichomonas vaginalis in

Index. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.

Received 16 December 2005/Returned for modification 6 February 2006/Accepted 6 May 2006

Advances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol

STI Multiplex Array. Rapid, simultaneous detection of 10 sexually transmitted infections

STI Multiplex Array. Rapid, simultaneous detection of 10 sexually transmitted infections

Optimal collection of first-void urine for detection of Chlamydia. trachomatis infection in men ACCEPTED. Beng T. Goh, 4 Helen H.

Setting The study setting was the community. The economic analysis was conducted in the USA.

GeneXpert System. On-Demand Molecular Testing for the Physician Office Laboratory

EDITOR S PICK ABSTRACT

Ten Years of Surveillance Data. B. Denise Stokich. A Master s Paper submitted to the faculty of. the University of North Carolina at Chapel Hill

Factors associated with repeat symptomatic gonorrhea infections among men who have sex with men, Bangkok, Thailand

Testing, Treating and Managing STIs Dr Jean Irvine

Duration of Persistence of Gonococcal DNA Detected by Ligase Chain Reaction in Men and Women following Recommended Therapy for Uncomplicated Gonorrhea

Evaluation of Nucleic Acid Amplification Tests as Reference Tests for Chlamydia trachomatis Infections in Asymptomatic Men

Chlamydia trachomatis and Neisseria gonorrhoeae are the two most commonly. crossm

Prevalence of human papillomavirus and bacteria as sexually transmitted infections in symptomatic and asymptomatic women

Outline. Trichomoniasis: Testing and Treatment Update. What s in a name? From the Greek: trichos, hair monas, unit, single

Sexually Transmitted Infections in Vulnerable Groups. Kevin Rebe

NIH Public Access Author Manuscript Arch Pediatr Adolesc Med. Author manuscript; available in PMC 2011 January 11.

Best practices in chlamydia (CT) and gonorrhea (GC) screening in a changing healthcare environment:

Outline. HIV and Other Sexually Transmitted Infections. Gonorrhea Epidemiology. Epidemiology 11/2/2012

Control and Prevention of Sexually Transmitted Infections; Chlamydia trachomatis. Dr Nathalie Broutet Department of Reproductive Health and Research

A School-based Chlamydia Control Program Using DNA Amplification Technology

Updated Guidelines for Post-Assault Testing and Treatment

Transcription:

NIH Public Access Author Manuscript Published in final edited form as: Sex Transm Infect. 2013 June ; 89(4): 305 307. doi:10.1136/sextrans-2012-050686. Comparison of self-obtained penile-meatal swabs to urine for the detection of C. trachomatis, N. gonorrhoeae and T. vaginalis Laura Dize 1, Patricia Agreda 1, Nicole Quinn 1, Mathilda R Barnes 1, Yu-Hsiang Hsieh 2, and Charlotte A Gaydos 1,2 1 Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, USA 2 Department of Emergency Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA Abstract Background Self-obtained penile-meatal swabs and urine specimens have been used for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV) for outreach screening in men. Objective To compare the sensitivity of self-collected male penile-meatal swabs and urine for the detection of CT, NG and TV. Methods Matching penile-meatal swabs and urines were collected at home after recruitment to the study; via the internet programme, http://www.iwantthekit.org. The instructions directed the participant to place the tip of a Copan flocked swab at the meatal opening of the urethra to collect the penile-meatal sample. Two ml of urine was collected after the swab onto a Copan sponge-ona-shaft collection device. Both swab and urine were placed into individual Aptima transport media tubes and mailed to the laboratory for testing. All specimens were tested for CT and NG using the GenProbe Aptima Combo2 Assay and for TV using GenProbe Aptima Analyte Specific Reagents with TV oligonucleotides. Results Of 634 men, 86 (13.6%) were positive for CT, 9 (1.4%) were positive for NG and 56 (9.3%) positive for TV. For CT, swab sensitivity was 81/86 (94.2%), and urine sensitivity was 66/86 (76.7%). For NG, swab sensitivity was 9/9 (100%) and urine sensitivity was 8/9 (88.9%). For TV, swab sensitivity was 45/56 (80.4%) and urine sensitivity was 22/56 (39.3%). Conclusions Self-obtained penile-meatal swabs provided for the detection of more CT, NG and TV, than urine specimens. Copyright Article author (or their employer) 2012. Correspondence to Dr Charlotte A Gaydos, Division of Infectious Diseases, School of Medicine, Room 530 Rangos Building, 855 North Wolfe Street, Baltimore, MD 21205-2196, USA; cgaydos@jhmi.edu. Contributors LD wrote the manuscript and contributed to performance of tests and provided statistics. PA was involved in testing of samples and data maintenance and wrote the manuscript. NQ was involved in testing of samples and data maintenance. MRB was the project coordinator, prepared kits and wrote the manuscript. CAG designed the study and wrote the manuscript. Y-HH provided statistical analysis of the data presented in this manuscript. Competing interests CAG has received research funding from Gen-probe and speaker honoraria. Ethics approval Johns Hopkins University Institutional Review Board. Provenance and peer review Not commissioned; externally peer reviewed. Data sharing statement There are no unpublished data from this study, but we will make available to others primary data output from the test platform such as Relative Light Units for samples tested.

Dize et al. Page 2 INTRODUCTION METHODS RESULTS In the USA, 19 million new cases of sexually transmitted infections (STIs), primarily affecting adolescents and young adults occur annually, costing $10 17 billion. 1 Chlamydia trachomatis is the most prevalent cause of bacterial STI reported to the Centers for Disease Control and Prevention (CDC). 2 The CDC recommends yearly screening for chlamydia in sexually active women <25 years of age, but not men. 3 Screening men for STIs is important because infected asymptomatic men can increase STI sequelae in their female partners. Nucleic acid amplifications tests (NAATs) are recommended by CDC as the test of choice, with urine being the specimen of choice for men. 4 Since urine samples are difficult to transport, the penilemeatal swab offers a potential alternative. Our internet programme, http://www.iwantthekit.org, has shown feasibility for testing home-collected specimens for STIs in men and women. 56 Our objective was to compare the sensitivity of self collected penile-meatal swabs and urines for the detection of C. trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) in men. From September 2006 November 2009, 634 men requested and submitted home collection kits for CT, NG and TV testing via http://www.iwantthekit.org. Participants were instructed to collect specimens as previously described. 6 Specimens were tested for CT and NG using Gen-Probe APTIMA Combo2 transcription-mediated amplification, according to manufacturer's instructions, and for TV using GenProbe APTIMA Analyte Specific Reagents with TV oligonucleotides. The cutoff for positive specimens for TV was >60 000 relative light units. 7 Discordant urine and swab results were tested for CT and NG using GenProbe APTIMA standalone assays, APTIMA Chlamydia trachomatis (ACT) or APTIMA Neisseria gonorrhoeae (AGC). Discordant testing was not performed for TV. Infected patient status for CT and NG were those who had two positive results by GenProbe Combo2 (urine and swab) or were ACT/AGC positive when specimens were discordant. In the case of TV, any positive specimen result was considered a true positive. This assay had been defined previously as highly sensitive and specific. 7 The study was approved by the Johns Hopkins University Institutional Review Board and written consent was obtained from participants. Of the 634 matching swabs and urines, 81 swabs and 66 urines were positive for CT; nine positives for NG by swab and eight by urine (table 1). Of these, 86 were considered to be CT infected (13.6%) and 9 (1.4%) were considered NG infected, after discordant sample analysis. The sensitivities of urines and swabs for CT were 76.7% (95% CI 67% to 84.8%) and 94.2% (95% CI 87.6% to 97.8%); for urines and swabs for NG were 88.9% (95% CI 56.1% to 99.4%) and 100% (95% CI 71.7% to 100.0%), respectively. Forty five swabs and 22 urines were positive for TV. By our definition, 56 (8.8%) were considered to be infected with TV. Of the 56 TV infected men, the sensitivities of urines and swabs were 39.3% (95% CI 27.2% to 52.5%) and 80.4% (95% CI 68.4% to 89.2%). From 634 matching specimens collected, there were 20 CT, 1 NG from urines and 34 TV urine results considered to be false-negatives, while for penile-meatal swabs there were 5 CT and 11 TV false-negative results (table 1).

Dize et al. Page 3 DISCUSSION Acknowledgments REFERENCES From September 2006 through 2009 the internet-based STI screening programme began enrolling men to determine if self-collected penile-meatal swabs would be a suitable method for testing men for CT, NG and TV. We demonstrated that in this study of home-collected samples, penile-meatal swabs performed better than urine specimens, when tested by the Gen-Probe assay. Sensitivities of swab and urine specimens for CT detection were 94.2% and 76.74% respectively, and for NG the sensitivity of penile-meatal swabs was 100% while the urine sensitivity was 88.89%, indicating excellent performance for swabs. Unlike other reports, for which glans swabs were used, we found that penile-meatal swabs out-performed urine specimens, perhaps because the swab only collected cells at the meatal orifice of the urethra, rather than the glans area. 910 Significant differences between swab specimens and urines were found when testing for TV: 45 swab specimens were positive, while 22 urine samples were positive. Sensitivities were 39.9% for urines and 80.4% for swab specimens, when any TV positive was considered to be a true positive. Swabs detected 34 more positives than urines, while urine detected 11 positive TV infections not detected by swabs. No explanation for these differences exists, except perhaps there is more lysis of TV in urine or there were differences during home selfcollection. The APTIMA TV assay is now US Food and Drug Administration cleared for women; it may be possible in the future to better confirm true positives for trichomonas in urine and swab samples, when further studies involving men are perfomed. 8 Determining the most sensitive collection method in men is highly desirable due to the fact that STI infections in men are often asymptomatic, resulting in the spread of infection to partners. Men are often hesitant to be screened for STIs due to the pain associated with the collection of intra-urethral swabs, so more comfortable penile-meatal swabs may overcome that barrier. It appeared that self-collected penile-meatal swabs were acceptable in our earlier study by questionnaires 6 and for those who participated in this study, since all men but eight submitted both sample types, while the directions listed the swab specimen as not required for study participation. There are limitations to our study. We were unable to ascertain whether samples were adequately self-collected by the men in our home sampling study. We instructed men to collect the penile-meatal swab first; however, we cannot confirm this was done. Our return rate of home-collection kits requested by men has been lower than 50% and may indicate the collection of penile swabs was not as acceptable as we measured through number of matched sample types returned. Internet testing programmes have eliminated some barriers that men in low- and high-risk populations face when screening is desired, including transportation, cost, stigma, and confidentiality. The results of this study show self-obtained penile-meatal swab specimens detected more positives than self-obtained urines. Further comparison testing of urine and penile-meatal swab specimens will be needed in order to conclude the best possible sample type when testing men for STIs. Funding U54EB007958, NIBIB, NIH; AI068613-01, NIH, NIAID. 1. Chesson HW, Blandford JM, Gift TL, et al. The estimated direct medical cost of sexually transmitted diseases among American Youth, 2000. Perspect Sex Reprod Health. 2004; 36:11 19. [PubMed: 14982672]

Dize et al. Page 4 2. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2010. US Department of Health and Human Services; Atlanta, GA: 2011. p. 1-155.2010. CDC 3. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines 2010. MMWR Dec 17 2010. 2010; 59:1 110. http://www.cdc.gov/std/treatment/2010. CDC. 4. Gaydos CA, Ferrero DV, Papp J. Laboratory aspects of screening men for Chlamydia trachomatis in the new millennium. Sex Tansmit Dis. 2008; 35(supple):S45 50. 5. Gaydos CA, Barnes M, Aumakham B, et al. Can E-technology through the Internet be used as a new tool to address the Chlamydia trachomatis epidemic by home sampling and vaginal swabs? Sex Tansmit Dis. 2009; 36:577 80. 6. Chai SJ, Aumakham B, Barnes M, et al. Internet-based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men. Sex Tansmit Dis. 2010; 37:756 63. 7. Hardick A, Hardick J, Wood BJ, et al. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J Clin Microbiol. 2006; 44:4197 9. [PubMed: 16943353] 8. Schwebke JR, Hobbs M, Taylor S, et al. Molecular testing for Trichomonas vaginalis in women: results of a pivotal US clinical trial. J Clin Microbiol. 2011; 49:4106 11. [PubMed: 21940475] 9. Moncada J, Schachter J, Liska S, et al. Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests. J Clin Microbiol. 2009; 47:1657 62. [PubMed: 19369445] 10. Raherison S, Peuchant O, Clerc M, et al. Glans swabs are not appropriate specimens for diagnosis of Chlamydia trachomatis infection in asymptomatic men. J Clin Microbiol. 2009; 47:2686. [PubMed: 19553578]

Dize et al. Page 5 Key messages Self-collected penile swabs collected at home performed better and identified more positive specimens than did urine samples for the detection of chlamydia, gonorrhoea and trichomonas by nucleic acid amplification tests. Internet recruited participation in home-collected urogenital samples may remove barriers, such as confidentiality and stigma, for men getting screened for sexually transmitted infections.

Dize et al. Page 6 Table 1 Comparison of penile swabs to urine specimen for detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis using nucleic acid amplification tests * Positive by swab Positive by urine True positives Swab sensitivity 95% CI swabs Urine sensitivity 95% CI urines Chlamydia trachomatis (CT) 81 66 86 94.2% 67.0 to 84.8 76.7% 87.6 to 97.8 Neisseria gonorrhoeae (NG) 9 8 9 100% 56.1 to 99.4 88.8% 71.7 to 100.0 Trichomonas vaginalis (TV) 45 22 56 80.4% 27.2 to 52.5 39.3% 68.4 to 89.2 * (n=634).